Correlation Between C4 Therapeutics and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Monte Rosa.
Diversification Opportunities for C4 Therapeutics and Monte Rosa
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between CCCC and Monte is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Monte Rosa go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Monte Rosa
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 1.28 times less return on investment than Monte Rosa. In addition to that, C4 Therapeutics is 1.28 times more volatile than Monte Rosa Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 943.00 in Monte Rosa Therapeutics on August 24, 2024 and sell it today you would lose (108.00) from holding Monte Rosa Therapeutics or give up 11.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
C4 Therapeutics vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| C4 Therapeutics |
| Monte Rosa Therapeutics |
C4 Therapeutics and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Monte Rosa
The main advantage of trading using opposite C4 Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |